Related references
Note: Only part of the references are listed.Regulation of matrix metalloproteinase 2 by oligomeric amyloid β protein
Wenjun Li et al.
BRAIN RESEARCH (2011)
Vascular endothelial growth factor signaling implicated in neuroprotective effects of placental growth factor in an in vitro ischemic model
Huan Du et al.
BRAIN RESEARCH (2010)
The impact of paracrine signaling in brain microvascular endothelial cells on the survival of neurons
Weihong Li et al.
BRAIN RESEARCH (2009)
Amyloid β Interaction with Receptor for Advanced Glycation End Products Up-Regulates Brain Endothelial CCR5 Expression and Promotes T Cells Crossing the Blood-Brain Barrier
Man Li et al.
JOURNAL OF IMMUNOLOGY (2009)
Matrix Metalloprotease-9 Inhibition Improves Amyloid β-Mediated Cognitive Impairment and Neurotoxicity in Mice
Hiroyuki Mizoguchi et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Matrix metalloproteinases-2 and-3 are reduced in cerebrospinal fluid with low beta-amyloid1-42 levels
Reinhilde Mlekusch et al.
NEUROSCIENCE LETTERS (2009)
Receptor for advanced glycation endproducts and atherosclerosis: From basic mechanisms to clinical implications
Giuseppina Basta
ATHEROSCLEROSIS (2008)
Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE(-/-) mice
Evis Harja et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
RAGE and soluble RAGE: Potential therapeutic targets for cardiovascular diseases
Hidenori Koyama et al.
MOLECULAR MEDICINE (2007)
Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease
Rashid Deane et al.
CURRENT ALZHEIMER RESEARCH (2007)
Secretion of brain-derived neurotrophic factor from brain microvascular endothelial cells
H Wang et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2006)
Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation
R Ramasamy et al.
GLYCOBIOLOGY (2005)
Preventing Activation of Receptor for Advanced Glycation Endproducts in Alzheimer's Disease
L-F Lue et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2005)
Inflammatory proteins in plasma and the risk of dementia - The Rotterdam study
MJ Engelhart et al.
ARCHIVES OF NEUROLOGY (2004)
Only cerebral capillary amyloid angiopathy correlates with Alzheimer pathology - a pilot study
J Attems et al.
ACTA NEUROPATHOLOGICA (2004)
The nature and effects of cortical microvascular pathology in aging and Alzheimer's disease
TL Bailey et al.
NEUROLOGICAL RESEARCH (2004)
Amyloid angiopathy-related vascular cognitive impairment
SA Greenberg et al.
STROKE (2004)
Nε-carboxymethyllysine in brain aging, diabetes mellitus, and Alzheimer's disease
X Gironés et al.
FREE RADICAL BIOLOGY AND MEDICINE (2004)
Inflammatory processes in Alzheimer's disease
EG McGeer et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2003)
Tissue inhibitors of matrix metalloproteinases are elevated in cerebrospinal fluid of neurodegenerative diseases
S Lorenzl et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2003)
Stromelysin-1 and gelatinase A are upregulated before TNF-α in LPS-stimulated neuroinflammation
S Mun-Bryce et al.
BRAIN RESEARCH (2002)
Alzheimer disease as a vascular disorder - Nosological evidence
JC de la Torre
STROKE (2002)
Metalloproteinases in biology and pathology of the nervous system
VW Yong et al.
NATURE REVIEWS NEUROSCIENCE (2001)
Share Paper
